| Sector: |
Healthcare |
| Industry: |
Biotechnology |
| Exchange: |
NASDAQ |
| Last Open: |
1.61 |
| Day Range: |
1.59 - 1.65 |
| Last Close: |
1.62 |
| Change: |
-0.01 (-0.01%) |
| Volume: |
120,615 |
| Avg Vol (3m): |
309,173 |
| 52wk Range: |
1.50 - 5.87 |
| Market Cap: |
68,400,000 |
| EBITDA: |
-13,700,000 |
| P/E Ratio: |
N/A |
|
(NABI) DIVIDEND RATINGS:
| Overall Rating: |
N/A |
| The overall rating is a weighted average of the three other rated categories listed below. It is a general indication of the health of a dividend. |
| Rating last changed: N/A |
|
| Dividend Yield: |
N/A |
| This indicator measures a stock's current dividend yield, and compares it to similar stocks and historical yields. |
| Dividend History: |
N/A |
| The rating for dividend history is determined by looking back at the frequency and amount of historical dividend payments. |
| Dividend Increases: |
N/A |
| This indicator measures a stock's history of dividend increases; consistent increases over time will produce a favorable rating. |
Learn More About Our Ratings
|
HEADLINES FOR (NABI):
OTHER BIOTECHNOLOGY COMPANIES:
|